ACR Appropriateness Criteria® external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II

ACR Appropriateness Criteria^® external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II

Adv Radiat Oncol. 2016 Oct 20;2(1):62-84. doi: 10.1016/j.adro.2016.10.002. eCollection 2017 Jan-Mar.

¹ Fox Chase Cancer Center, Philadelphia, Pennsylvania (research author).
² University of Virginia, Charlottesville, Virginia (principal author).
³ Mayo Clinic, Phoenix, Arizona (research author, contributing).
⁴ Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts (panel vice-chair).
⁵ University of Alabama School of Medicine, Birmingham, Alabama (American Urological Association).
⁶ Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts (American Society of Clinical Oncology).
⁷ University of California San Francisco, San Francisco, California.
⁸ William Beaumont Hospital, Troy, Michigan.
⁹ Mayo Clinic, Scottsdale, Arizona.
¹⁰ The University of Chicago Medical Center, Chicago, Illinois.
¹¹ Huntsman Cancer Hospital, Salt Lake City, Utah.
¹² University of Michigan, Novi, Michigan.
¹³ Henry Ford Health System, Detroit, Michigan.
¹⁴ Bon Secours Cancer Institute, Norfolk, Virginia.
¹⁵ Mills Peninsula Hospital, San Mateo, California.
¹⁶ University of Pennsylvania, Philadelphia, Pennsylvania.
¹⁷ Mayo Clinic, Rochester, Minnesota (panel chair).

No abstract available